Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 80425-0019

4 FDA label images from Advanced Rx Of Tennessee, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 80425-0019). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of Cyclobenzaprine Hydrochloride is shown, depicting the molecular arrangement of the active ingredient as part of this human prescription drug.*
FDA Label Image

Labe 1 (Label 1)

Labe 1 (Label 1)
Cyclobenzaprine Hydrochloride 10 mg film-coated tablets in a labeled package from Advanced Rx of Tennessee, LLC. The label includes storage instructions, lot number, expiration date 1/31/2024, and a comparison reference to Flexeril. It shows the package count as 30 tablets and a barcode below the text.*
FDA Label Image

Label 2 (Label 2)

Label 2 (Label 2)
Cyclobenzaprine HCL 10 mg tablet packaging label shows the proprietary and nonproprietary name Cyclobenzaprine Hydrochloride. The label indicates it is a film-coated oral tablet, packaged by AdvancedRx of Tennessee, LLC, Nashville, TN. Contains barcodes, lot number 60CYC10124, expiration date 1/31/2024, and references comparison to FLEXERIL.*
FDA Label Image

Lab 3 (Label 3)

Lab 3 (Label 3)
Label for Cyclobenzaprine Hydrochloride 10 mg film-coated tablets, distributed by Advanced Rx of Tennessee, LLC. The label includes a comparison to FLEXERIL, lot number, expiration date of 1/31/2024, a barcode, and storage instructions to keep at 20°-25°C. The product is oral tablet form with NDC 80425-0019.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.